Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.6705
-0.00165-0.25%
Last update: Aug 18, 2:04 PM
Outlook Therapeutics Inc
OTLKNASDAQ
Earnings: Q3 2026 Earnings were released on Fri Aug 14th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 4 days agoClick to view the webcast
Outlook Therapeutics Market Sentiment
Market sentiment signals for Outlook Therapeutics (OTLK): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▼ 11.5% short float
Options Flow▲ 0.04 P/C ratio
Insider Activity▲ Net Buyer (30d)
Analyst Consensus
Buy
9 analysts
Options Flow (P/C)
0.04
More calls — Bullish
2,836 calls · 104 puts
Avg Consensus PT
$3
+414.5%
Highest Price Target
$10
+1391.3%
Ascendiant Capital
Lowest Price Target
$1
+49.1%
Chardan Capital
Short Interest
11.5%
Rising — Bearish
Insider Activity (30d)
Net Buyer
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | BTIG | Julian Harrison— | +496.5% | $4 → $4 | Maintained | Buy |
| Jul 27, 2026 | HC Wainwright & Co. | Douglas Tsao— | +138.6% | $1 → $2 | Maintained | Neutral |
